Citations

Gregson, J., P. Kaleebu, V. C Marconi, C. van Vuuren, N. Ndembi, R. L Hamers, P. Kanki, C. J Hoffmann, S. Lockman, D. Pillay, T. de Oliveira, N. Clumeck, G. Hunt, B. Kerschberger, R. W Shafer, C. Yang, E. Raizes, R. Kantor, and R. K Gupta. "Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study." Lancet Infect Dis 17, no. 3 (2017): 296-304.

Gupta, R. K, J. Gregson, N. Parkin, H. Haile-Selassie, A. Tanuri, L. Andrade Forero, P. Kaleebu, C. Watera, A. Aghokeng, N. Mutenda, J. Dzangare, S. Hone, Z. Z Hang, J. Garcia, Z. Garcia, P. Marchorro, E. Beteta, A. Giron, R. Hamers, R. Inzaule, L. M Frenkel, M. H Chung, T. de Oliveira, D. Pillay, K. Naidoo, A. Kharsany, R. Kugathasan, T. Cutino, G. Hunt, S. Avila Rios, M. Doherty, M. R Jordan, and S. Bertagnolio. "HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis." Lancet Infect Dis 18, no. 3 (2018): 346-355.

Kiguoya, M. W, J. K Mann, D. Chopera, K. Gounder, G. Q Lee, P. W Hunt, J. N Martin, T. B Ball, J. Kimani, Z. L Brumme, M. A Brockman, and T. Ndung'u. "Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression." J Virol 91, no. 13 (2017).

Lippman, S. A, A. C Mooney, A. Puren, G. Hunt, J. S Grignon, L. M Prach, H. J Gilmore, H. M Truong, S. Barnhart, and T. Liegler. "The role of drug resistance in poor viral suppression in rural South Africa: findings from a population-based study." BMC Infect Dis 20, no. 1 (2020).